Discounted Cash Flow Rating
Sell
Return on Equity Rating
Neutral
Debt to Equity Rating
Sell
Price to Earnings Rating
Strong Buy
Analyst Rating
Neutral
Simple Moving Average
Sell
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Zura Bio Limited Class A Ordinary Shares (ZURA)
Biological Products, (no Disgnostic Substances)
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.
4225 EXECUTIVE SQUARE, SUITE 600
LA JOLLA, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
03/21/2023
Market Cap
221,111,310
Shares Outstanding
43,590,000
Weighted SO
43,093,685
Total Employees
N/A
Upcoming Earnings
08/12/2024
Similar Tickers
Beta
0.1490
Last Div
0.0000
Range
2.0-7.634
Chg
0.0100
Avg Vol
294570
Mkt Cap
221111310
Exch
NASDAQ
Country
US
Phone
858 247 0520
DCF Diff
0.2514
DCF
3.0186
Div Yield
0.0000
P/S
0.0000
EV Multiple
-0.7666
P/FV
1.5753
Div Yield %
0.0000
P/E
-8.1813
PEG
0.0084
Payout
0.0000
Current Ratio
12.5705
Quick Ratio
12.5705
Cash Ratio
12.5020
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
0.2321
ROA
-0.1590
ROE
-0.3545
ROCE
-0.2359
NI/EBT
0.8656
EBT/EBIT
0.8461
EBIT/Rev
0.0000
Debt Ratio
0.0000
D/E
0.0000
LT Debt/Cap
0.0000
Total Debt/Cap
0.0000
Int Coverage
0.0000
CF/Debt
0.0000
Equity Multi
1.2107
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-0.2431
FCF/Share
-0.3401
Cash/Share
2.5143
OCF/Sales
0.0000
FCF/OCF
1.3988
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
-2.5076
Div&CapEx Cov
-2.5076
P/BV
1.5753
P/B
1.5753
P/S
0.0000
P/E
-8.1813
P/FCF
-8.6744
P/OCF
-13.5311
P/CF
-13.5311
PEG
0.0084
P/S
0.0000
EV Multiple
-0.7666
P/FV
1.5753
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
4.19M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
1.45M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2022 | 2023 | 2024 | 1970 | 1970 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | ||||
Cost Of Revenue | 0.00 | 0.00 | 0.00 | ||||
Gross Profit | 0.00 | 0.00 | 0.00 | ||||
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | ▼ | |||
Research And Development Expenses | 415.00K | ▲ 6.92M | ▼ 3.59M | ▼ | |||
General And Administrative Expenses | 653.00K | ▲ 3.91M | ▲ 4.79M | ▼ | |||
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | ||||
Selling General And Administrative Expenses | 653.00K | ▲ 3.91M | ▲ 4.79M | ▼ | |||
Other Expenses | 0.00 | ▲ 24.00K | ▼ 23.00K | ▼ | |||
Operating Expenses | 1.07M | ▲ 10.83M | ▼ 8.38M | ▼ | |||
Cost And Expenses | 1.07M | ▲ 10.83M | ▼ 8.38M | ▼ | |||
Interest Income | 0.00 | ▲ 1.37M | ▼ 1.22M | ▼ | |||
Interest Expense | 0.00 | 0.00 | 0.00 | ||||
Depreciation And Amortization | 34.00K | ▼ -960.00K | ▲ 606.00K | ▼ | |||
Ebitda | -1.03M | ▼ -11.79M | ▲ -7.77M | ▼ | |||
Ebitda Ratio | 0.00 | 0.00 | 0.00 | ▼ | |||
Operating Income | -1.07M | ▼ -10.83M | ▲ -8.38M | ▼ | |||
Operating Income Ratio | 0.00 | 0.00 | 0.00 | ▼ | |||
Total Other Income Expenses Net | -34.00K | ▲ 984.00K | ▼ -583.00K | ▼ | |||
Income Before Tax | -1.10M | ▼ -8.47M | ▲ -7.75M | ▼ | |||
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | ▼ | |||
Income Tax Expense | 0.00 | ▼ -1.37M | ▼ -8.23M | ▼ | |||
Net Income | -1.10M | ▼ -8.47M | ▲ -730.00K | ▼ | |||
Net Income Ratio | 0.00 | 0.00 | 0.00 | ▼ | |||
Eps | -0.06 | ▼ -0.18 | ▲ -0.02 | ▼ | |||
Eps Diluted | -0.06 | ▼ -0.18 | ▲ -0.02 | ▼ | |||
Weighted Average Shs Out | 17.25M | ▲ 47.05M | ▼ 46.91M | ▼ | |||
Weighted Average Shs Out Dil | 17.25M | ▲ 47.05M | ▼ 46.91M | ▼ |